Wuhan Coronavirus Resource Thread
Re: Wuhan Coronavirus Resource Thread
Chetak,
Get off the samajwad train please.
Open market operations are perfectly legitimate ways to raise funds. The investors will lap it up and make money many times over in open market operations. The returns are guaranteed. The market is more or less captive.
It's not like the government has nationalised the production of the vaccine. With SII not getting paid for the production.
Secondly, it not like the additional capacity cannot not be utilised for contract manufacturing of other drugs by SII Once covid is over.
So what are the exact downsides of SII raising funds from the market. In order to build capacity.
Get off the samajwad train please.
Open market operations are perfectly legitimate ways to raise funds. The investors will lap it up and make money many times over in open market operations. The returns are guaranteed. The market is more or less captive.
It's not like the government has nationalised the production of the vaccine. With SII not getting paid for the production.
Secondly, it not like the additional capacity cannot not be utilised for contract manufacturing of other drugs by SII Once covid is over.
So what are the exact downsides of SII raising funds from the market. In order to build capacity.
Re: Wuhan Coronavirus Resource Thread
there is no samajwad train.Pratyush wrote:Chetak,
Get off the samajwad train please.
Open market operations are perfectly legitimate ways to raise funds. The investors will lap it up and make money many times over in open market operations. The returns are guaranteed. The market is more or less captive.
It's not like the government has nationalised the production of the vaccine. With SII not getting paid for the production.
Secondly, it not like the additional capacity cannot not be utilised for contract manufacturing of other drugs by SII Once covid is over.
So what are the exact downsides of SII raising funds from the market. In order to build capacity.
It's called supporting your own and being grateful for help received when SII could have slowed down production by quoting any number of complex and valid technical reasons that simply could not have been disputed by any illiterate govt idiot
If market metrics are being quoted now, SII should have been freed right from the beginning. This is why all business in India are screwed. We are going back to the neverwho days when the IAS babooze dominated and ministers used the chit bhi meri, pat bhi meri aur sikka mere baap ka technique
with foreign manufacturers flooding into India, vaccine pricing controls are effectively out the window, "Indian enterprise" will ensure hoarding, cornering of big name vaccines, diversion, and black marketing, as well as, big time smuggling to "neighbors" like pak, lanka, nepal, and beediland
these foreign manufacturers, fully supported and funded by their govts are trying to knock the bottom out of India's primacy in the vaccine production field and at the same time gain access to the vast Indian covid vaccine market and the govt has allowed them all in and simultaneously kicked the stuffing out of SII and other Indian manufacturers.
The greedy goras want access to India's huge markets but at the same time, they are very sure about not allowing Indian manufactured vaccines into their markets. It's the same old east India company story all over again with the same white skins looking down on the kaalu Indians
India has a huge vaccine hesitancy problem due to religious as well as economic considerations. The lower strata will not get vaccinated even if you paid them. Every hospital or govt vaccine center is proof enough that only some of the educated middle classes are getting vaccinated. The rest simply do not go.
even the healthcare workers, especially muslims have not fully agreed to get vaccinated.
there is a growing perception that vaccines given free at the govt centers are not as good as the vaccines given at the hospitals on payment, even though both vaccines are exactly the same.
you will not see any autoriksha driver or plumber or carpenter in the vaccine line or muslims
Also, the juice has been squeezed out of Indian suppliers like SII and some others
The govt has now panicked and is allowing every tom, dick, and any other vaccine producing prick into India.
The pressure from the amerikis and big pharma which even apro Modi has not been able to withstand has broken the dam
which is also why the russian sputnik vaccine has been cleared before the others.
Drug Controller Clears Govt's Recommendation , Now Sputnik V is Officially 3rd #CoronaVaccine of India. It has 91.6% Efficacy against Covid and 100% Efficacy against Severe #COVID19
https://www.hindustantimes.com/india-ne ... 60979.htmlIndia has exempted foreign-made Coronavirus disease (Covid-19) vaccines from conducting local bridging studies before seeking emergency-use authorisation, provided they have received approval from any of the major regulators globally, the government announced on Tuesday.
The move is a part of the centre’s efforts to fast track emergency approvals for foreign-produced Covid-19 vaccines (that have been granted approval in other countries) to expand the basket of vaccines for domestic use, and hasten the pace and coverage of Covid-19 vaccination.
“The National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), after comprehensive deliberation, recommended that vaccines for Covid-19, which have been developed & are being manufactured in foreign countries and which have been granted emergency approval for restricted use by USFDA, EMA, UK MHRA, PMDA Japan or which are listed in WHO(Emergency Use Listing) may be granted emergency use approval in India, mandating the requirement of post-approval parallel bridging clinical trial in place of conduct of local clinical trial as per the provisions prescribed under Second Schedule of the New Drugs & Clinical Trials Rules 2019,” said the Union health ministry in a statement.
The expert vaccine panel also suggested that the first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before further immunisation takes place within the country.
Re: Wuhan Coronavirus Resource Thread
and the hans are admitting defeat as far as their home made vaccines go
If only our vaccine was as good as our virus, the official lamented (whatsapp)
If only our vaccine was as good as our virus, the official lamented (whatsapp)
Re: Wuhan Coronavirus Resource Thread
Govt fast-tracks approval for foreign-produced COVID-19 vaccines cleared in other countries
* Increase compensation for private hospitals. Rs 100 for a shot is really low. (I used to pay Rs 50 for a 15-minute consultation about 25 years ago. I am sure the prices have gone up).
* Let private businesses import vaccines approved using the above criteria and use it as the private sector deems fit.
* Need for a massive public awareness campaign to reduce vaccine hesitancy.
* Compensate poor for taking the vaccine. Many people suffer side effects for a day or two. Those are the days of lost wages. Poor should be compensated for that. Vaccinating everybody is not only in the interest of the person getting the shot but also in the interest of the entire nation.
This is the time to increase vaccinations. 40 lakhs even during the Vaccine Utsav is not enough.
This is awesome. I am glad the Central govt. is showing the agility required to control this pandemic. I hope they will take the following steps as well:The government has decided that COVID-19 vaccines which have been developed and are being manufactured in foreign countries and which have been granted emergency approval for restricted use by authorities in the US, Europe, the UK, Japan or which are listed in the WHO Emergency Use Listing may be granted emergency use approval in India.
* Increase compensation for private hospitals. Rs 100 for a shot is really low. (I used to pay Rs 50 for a 15-minute consultation about 25 years ago. I am sure the prices have gone up).
* Let private businesses import vaccines approved using the above criteria and use it as the private sector deems fit.
* Need for a massive public awareness campaign to reduce vaccine hesitancy.
* Compensate poor for taking the vaccine. Many people suffer side effects for a day or two. Those are the days of lost wages. Poor should be compensated for that. Vaccinating everybody is not only in the interest of the person getting the shot but also in the interest of the entire nation.
This is the time to increase vaccinations. 40 lakhs even during the Vaccine Utsav is not enough.
Re: Wuhan Coronavirus Resource Thread
@Uttam
Rs 100 fetches one a fairly decent meal almost anywhere in India.
Globally, everyone including India, is following well considered, approved and a safe vaccination protocol.
when the amerikis start to vaccinate everyone, do please let us know.
Rs 100 fetches one a fairly decent meal almost anywhere in India.
and what about pappu screaming "scam and kickbacks" with the congis, commies, urban naxals and lootyens presstitutes joining in the chorus along with NYT, the guardian, WAPO, al jazera and BBC supported by countless others, all piling on as part of the global anti Modi orchestra and playing their signature tune to defame Modi, Hindus, India and the RSS* Increase compensation for private hospitals. Rs 100 for a shot is really low. (I used to pay Rs 50 for a 15-minute consultation about 25 years ago. I am sure the prices have gone up).
* Let private businesses import vaccines approved using the above criteria and use it as the private sector deems fit.
no country in the world is vaccinating everyone and nor is anyone advocating such foolishness.Vaccinating everybody is not only in the interest of the person getting the shot but also in the interest of the entire nation.
Globally, everyone including India, is following well considered, approved and a safe vaccination protocol.
when the amerikis start to vaccinate everyone, do please let us know.
Last edited by chetak on 13 Apr 2021 19:12, edited 1 time in total.
Re: Wuhan Coronavirus Resource Thread
We either worry about what lib-tards are shouting or take care of our own. Letting private businesses import the vaccine if they can is not a scandal. If anything, this will take away taking points from capitalist lib-tards like Bloomberg. AND if this step helps in making more vaccines available, then so be it.chetak wrote:@Uttam
Rs 100 fetches one a fairly decent meal almost anywhere in India.
and what about pappu screaming "scam and kickbacks" with the congis, commies, urban naxals and lootyens presstitutes joining in the chorus along with NYT, the guardian, WAPO, al jazera and BBC along with countless others piling on as part of the global orchestra playing their signature tune to defame Modi and the RSS* Increase compensation for private hospitals. Rs 100 for a shot is really low. (I used to pay Rs 50 for a 15-minute consultation about 25 years ago. I am sure the prices have gone up).
* Let private businesses import vaccines approved using the above criteria and use it as the private sector deems fit.
With regards to increasing compensation for private hospitals, remember these private hospitals will still have to compete against the price paid at govt. facilities, where the price is Rs 0.00.
Re: Wuhan Coronavirus Resource Thread
Well said, chetakji. Boeing is openly supported in a strategic business sector by their goverment, so supporting SII is the smart thing to do if India wants to be a leader in this sector. India owes SII for its service to the country at a time of need. Just a low interest loan from public funds with relaxed repayment terms would do. Helps SII and does not give away public monies.chetak: If you are serious about the atmanirbhar thing, then help out this totally Indian owned company to help you..
Re: Wuhan Coronavirus Resource Thread
It's a net loss making effort for the large private hospitals that are participating in the vaccination effort. They are doing it out of genuine CSR feeling or out of guilt for the fleecing they are doing of their covid patients.
Re: Wuhan Coronavirus Resource Thread
many private hospitals have paid off govt agencies to divert vaccination walk-ins to the hospitals by ensuring poor coverage at govt centers.Uttam wrote:We either worry about what lib-tards are shouting or take care of our own. Letting private businesses import the vaccine if they can is not a scandal. If anything, this will take away taking points from capitalist lib-tards like Bloomberg. AND if this step helps in making more vaccines available, then so be it.chetak wrote:@Uttam
Rs 100 fetches one a fairly decent meal almost anywhere in India.
and what about pappu screaming "scam and kickbacks" with the congis, commies, urban naxals and lootyens presstitutes joining in the chorus along with NYT, the guardian, WAPO, al jazera and BBC along with countless others piling on as part of the global orchestra playing their signature tune to defame Modi and the RSS
With regards to increasing compensation for private hospitals, remember these private hospitals will still have to compete against the price paid at govt. facilities, where the price is Rs 0.00.
This private hospitals' "business model" started off very early in the game
Re: Wuhan Coronavirus Resource Thread
private hospitals are bottom line driven, period.a_bharat wrote:It's a net loss making effort for the large private hospitals that are participating in the vaccination effort. They are doing it out of genuine CSR feeling or out of guilt for the fleecing they are doing of their covid patients.
they are all using existing facilities and existing staff. Many are running the vaccination work in their lobbys, basements and underground parking facilities.
Na biwi na bacha na baap bada na maiya (na CSR)
The whole thing is that ke bhaiya sabse bada rupaiya
Re: Wuhan Coronavirus Resource Thread
https://www.rediff.com/news/report/us-r ... 210413.htm
US regulators recommend pause on J&J vaccine over rare blood clots
Edited By: Roshneesh Kmaneck, April 13, 2021
The United States’ Centers of Disease Control and Prevention and the US Food and Drug Administration have recommended a "pause" in the use of Johnson and Johnson COVID-19 vaccine "out of an abundance of caution" over six reported cases in the US of a "rare and severe" type of blood clot.
In a joint statement, the CDC and the FDA said they were investigating clots in six women in the days after vaccination, in combination with reduced platelet count. The six reported cases were among more than 6.8 million doses of the Johnson & Johnson vaccine administered in the United States.
All six cases occurred among women ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination, according to Dr Anne Schuchat, principal deputy director of the CDC and Dr Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
"CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review these cases and assess their potential significance," the statement said.
......
Gautam
US regulators recommend pause on J&J vaccine over rare blood clots
Edited By: Roshneesh Kmaneck, April 13, 2021
The United States’ Centers of Disease Control and Prevention and the US Food and Drug Administration have recommended a "pause" in the use of Johnson and Johnson COVID-19 vaccine "out of an abundance of caution" over six reported cases in the US of a "rare and severe" type of blood clot.
In a joint statement, the CDC and the FDA said they were investigating clots in six women in the days after vaccination, in combination with reduced platelet count. The six reported cases were among more than 6.8 million doses of the Johnson & Johnson vaccine administered in the United States.
All six cases occurred among women ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination, according to Dr Anne Schuchat, principal deputy director of the CDC and Dr Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
"CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review these cases and assess their potential significance," the statement said.
......
Gautam
Re: Wuhan Coronavirus Resource Thread
A very informative article written by Suraj on Swarajya:
The Covid-19 ‘Vaccine Shortage’: What Is Really Happening?
Suraj: thanks for this article. I really appreciate you putting together data for production versus consumption. Looks like somebody in the govt. heard your recommendation immediately
We also need a more in-depth understanding of vaccine consumption in terms of who is getting vaccinated and who is avoiding it.
The Covid-19 ‘Vaccine Shortage’: What Is Really Happening?
Suraj: thanks for this article. I really appreciate you putting together data for production versus consumption. Looks like somebody in the govt. heard your recommendation immediately
2. Expedite EUAs of vaccines currently in trials. If necessary, incentivise pre-production as SII and Bharat Biotech did, so that stockpiles are available as soon as approvals come.
We also need a more in-depth understanding of vaccine consumption in terms of who is getting vaccinated and who is avoiding it.
Re: Wuhan Coronavirus Resource Thread
Haha yes I, glad to hear that this recommendation was immediately followed but I think it was coincidence
Re: Wuhan Coronavirus Resource Thread
US attack on UK vaccine escalates! J&J single shot covid vaccine blocked in US for 6 cases of blood clots in 7 million people,
US agencies call for pause in Johnson & Johnson vaccine
https://www.bbc.co.uk/news/world-us-canada-56733715
Re: Wuhan Coronavirus Resource Thread
Is there a process delta in the clinical trials conducted in India Vs that in the US or EU ? If not why can't we provide emergency approval based on the successful clinical trials and approvals by the European commission and US FDA ?
Re: Wuhan Coronavirus Resource Thread
India administers 10.85 cr COVID-19 vaccine doses so far
A total of 10,85,33,085 vaccine doses have been administered through 16,08,448 sessions, as per the provisional report till 7 am today.
"These include 90,33,621 HCWs who have taken the 1st dose and 55,58,103 HCWs who have taken the 2nd dose, 1,00,78,589 FLWs (1stdose), 49,19,212 FLWs (2nddose), 4,17,12,654 1st dose beneficiaries and 22,53,077 2nd dose beneficiaries more than 60 years old and 3,42,18,175 (1st dose) and 7,59,654 (2nd dose) beneficiaries aged 45 to 60 years," the Ministry said.
As on day-87 of the COVID-19 vaccination drive (April 12, 2021), 40,04,521 vaccine doses were given. Out of which, 34,55,640 beneficiaries were vaccinated across 52,087 sessions for the first dose and 5,48,881 beneficiaries received 2nd dose of the vaccine.
"In terms of the number of daily doses administered globally, India continues to remain at the top with an average of 41,69,609 doses administered per day," it said.
Re: Wuhan Coronavirus Resource Thread
Ha Ha! Johnson and Johnson is a US drug company. Maybe you are thinking the it is a UK company because the UK PM is a Johnson too. It is a very common name. The J&J vaccine is actually made by a subsidiary of J&J called Janssen in Belgium. So nothing to do with the UK.IndraD wrote:US attack on UK vaccine escalates! J&J single shot covid vaccine blocked in US for 6 cases of blood clots in 7 million people,US agencies call for pause in Johnson & Johnson vaccine
https://www.bbc.co.uk/news/world-us-canada-56733715
Re: Wuhan Coronavirus Resource Thread
https://swarajyamag.com/politics/the-co ... -happening
Analysing The Second Wave: The Worst Should Be Over In Three Weeks
Analysing The Second Wave: The Worst Should Be Over In Three Weeks
As the chart above shows, the fastest climbers of the second wave are Maharashtra, Chhattisgarh, Karnataka, Punjab, Delhi and Tamil Nadu. Close behind, with a slightly delayed start are Rajasthan, West Bengal, Haryana, Uttar Pradesh, Bihar and Gujarat. As usual, the Kerala numbers make little sense.
We see that kick-off times for the second wave vary from state to state by a month. And in Kerala and Maharashtra, it is as if the epidemic never really abated (this was actually flagged by Swarajya on multiple occasions in the past, since the cumulative positivity levels in both these states remained so high for so long, in spite of an ostensible reduction in case counts on paper).
The second point is that case counts are rising this steeply because testing is already at very high levels. As a result, there is negligible lead time between a spurt in cases and a concomitant rise in testing levels.
This is the main difference between the two waves, and also the reason why infected carriers are being tracked and isolated so swiftly. (Readers would remember that the slow, inexorable rise of cases in 2020 was primarily because most states took three to four months to develop requisite testing capacities; that lag time is absent now)
The third point is the most important: an analysis of current trends vis-a-vis historical data indicates that the worst of the second wave should be over in about three weeks.
Why do we say this? The reason is empirical: last year’s data of June-July onwards, from many dozens of badly-affected jurisdictions (after the nation-wide lockdowns were relaxed), shows that once testing ramped up to requisite levels, and local administrators diligently enforced tracing and isolation protocols of infected individuals, both daily case counts and cumulative positivity began to reduce consistently in about three weeks.
As a second chart below shows, both case counts and positivity began to dip over a three-week period, once countrywide testing ramped up to requisite levels in late July. The critical period is marked by a yellow oval. Note how positivity (orange line) and case counts (red line) start to plateau once daily testing (purple line) starts to edge towards the million-per-day mark:
Re: Wuhan Coronavirus Resource Thread
https://swarajyamag.com/politics/the-co ... -happening
The Covid-19 ‘Vaccine Shortage’: What Is Really Happening?
Suraj's article.
The Covid-19 ‘Vaccine Shortage’: What Is Really Happening?
Suraj's article.
However, it remains fundamentally in a position to maintain the current vaccination rate without any slowdown until production ramps up in summer.
The government is significantly overperforming on its original goals, which was to do 200-250 million vaccinations by July — the above chart shows that it will perform over double that number — 530 million at a current ongoing rate. The increase was driven by the second wave that hit India in March, accelerating the need to vaccinate the most at risk groups quickly.
The above chart only considers Covishield and Covaxin production. Several others are in the process of clearing trials in India, according to ICMR data. Among these, Sputnik V has received clearance for emergency use, with production by Dr Reddy’s Labs. SII is due to begin production of Corovax, the licenced Novavax, starting in July/August.
-
- BRF Oldie
- Posts: 10040
- Joined: 31 May 2004 11:31
- Location: The rings around Uranus.
Re: Wuhan Coronavirus Resource Thread
The US has already attacked the Oxford-AZ vaccine known as Covishield in India. The US is sitting on 300 million doses and has not approved the AZ vaccine for the US and was supposed to send it to different places around the world, but don't know if that happened yet.Aldonkar wrote:Ha Ha! Johnson and Johnson is a US drug company. Maybe you are thinking the it is a UK company because the UK PM is a Johnson too. It is a very common name. The J&J vaccine is actually made by a subsidiary of J&J called Janssen in Belgium. So nothing to do with the UK.IndraD wrote:US attack on UK vaccine escalates! J&J single shot covid vaccine blocked in US for 6 cases of blood clots in 7 million people,
-
- BRF Oldie
- Posts: 10040
- Joined: 31 May 2004 11:31
- Location: The rings around Uranus.
Re: Wuhan Coronavirus Resource Thread
Good article, Surajsan. It really points out that India is ahead of other entire continents or right at par with North America as a whole.Suraj wrote:Haha yes I, glad to hear that this recommendation was immediately followed but I think it was coincidence
Re: Wuhan Coronavirus Resource Thread
And that is with the second largest population and per capita income of a little over $2000. Let's not forget that all this vaccine and vaccination takes enormous amounts of money.Mort Walker wrote:Good article, Surajsan. It really points out that India is ahead of other entire continents or right at par with North America as a whole.Suraj wrote:Haha yes I, glad to hear that this recommendation was immediately followed but I think it was coincidence
It also takes medical staff. India has less 1 doctor per 1000 people, (North America has 2.6, EU has 3.7, etc.
If this is not commendable then I don't know what is.
Re: Wuhan Coronavirus Resource Thread
2.5 million vaccinations until 8pm on Tuesday. Total over 111 million
https://www.pib.gov.in/PressReleseDetai ... ID=1711602
https://www.pib.gov.in/PressReleseDetai ... ID=1711602
Re: Wuhan Coronavirus Resource Thread
More than 25 lakh doses administered across the Country till 8 PM today
The cumulative number of COVID19 vaccine doses administered in the country stands at 11,10,33,925 as per the 8 pm provisional report today.
Re: Wuhan Coronavirus Resource Thread
Man would it suck to do this year after year. If we are facing shortages now due to raw materials being "held up" in EU and Massa, we may have trouble scaling up next year as well.Suraj wrote:2.5 million vaccinations until 8pm on Tuesday. Total over 111 million
https://www.pib.gov.in/PressReleseDetai ... ID=1711602
Re: Wuhan Coronavirus Resource Thread
There was an article posted earlier in this thread where SII CEO says that the shortage is in low tech manufacturing items that India can be self-sufficient in no time -- like plastic tubes, bags, and things like that.
Re: Wuhan Coronavirus Resource Thread
We have to control our own supply chain here. We have almost everything in house already. We just have to support it. The parable of defense supplies and stuff hitting the fan in wartime applies here too. All those advance payments by EU and US mean nothing when they cannot produce, hoard, keep from each other and break contractual agreements when people start dying.
So far we have managed great. There's no change to take our eyes off the ball here though. There's a critical period where all plans need to continue to align, and we will ride it out.
So far we have managed great. There's no change to take our eyes off the ball here though. There's a critical period where all plans need to continue to align, and we will ride it out.
Re: Wuhan Coronavirus Resource Thread
FWIW
COVID-19: Lockdown is main reason for drop in coronavirus cases and deaths - not vaccinations, says Boris Johnson
https://news.sky.com/story/covid-19-loc ... n-12274266
COVID-19: Lockdown is main reason for drop in coronavirus cases and deaths - not vaccinations, says Boris Johnson
https://news.sky.com/story/covid-19-loc ... n-12274266
Re: Wuhan Coronavirus Resource Thread
A third of COVID-19 survivors in a study of more than 230,000 mostly American patients were diagnosed with a brain or psychiatric disorder within six months, suggesting the pandemic could lead to a wave of mental and neurological problems
https://www.reuters.com/article/us-heal ... SKBN2BT2ZI
https://www.reuters.com/article/us-heal ... SKBN2BT2ZI
Re: Wuhan Coronavirus Resource Thread
Nasal vaccine is the answer and we need to distribute it in a 20 Rs bottle that can be self servicedpgbhat wrote:Man would it suck to do this year after year. If we are facing shortages now due to raw materials being "held up" in EU and Massa, we may have trouble scaling up next year as well.Suraj wrote:2.5 million vaccinations until 8pm on Tuesday. Total over 111 million
https://www.pib.gov.in/PressReleseDetai ... ID=1711602
Re: Wuhan Coronavirus Resource Thread
Are there any trends about the death rates over the last 2-3 weeks? Is it about the same or lower or worse? I can’t seem to get the data from the usual mohfw site...
Re: Wuhan Coronavirus Resource Thread
Ishita Joshi
@IshitaJoshi
Network of Plasma donors ... in case anyone needs plasma, put request here.
https://pintnetwork.com/home
@IshitaJoshi
Network of Plasma donors ... in case anyone needs plasma, put request here.
https://pintnetwork.com/home
Re: Wuhan Coronavirus Resource Thread
https://www.covid19india.org/Tanaji wrote:Are there any trends about the death rates over the last 2-3 weeks? Is it about the same or lower or worse? I can’t seem to get the data from the usual mohfw site...
Daily
Cumulative
Re: Wuhan Coronavirus Resource Thread
Absolute death count is starting to inch towards record highs. In Gujarat, the crematoriums are starting to get maxxed out. If the trends don't change, we are not going to be able to avoid lockdown type of a situation in most of our major cities. We can say good bye to lofty growth targets for 2021
Re: Wuhan Coronavirus Resource Thread
Lockdown is no answer. You just delay the inevitable. Its more a political gimmick to say to world that we are doing something. What maha is offering to poor people for 15 day lockdown. 3kg wheat and 2 kg rice worth Rs 120 for 7 Cr poor people.
Better would have been to cut 20 percent yearly pay of 2 million employees to pay Rs 40000 Cr to poor people instead of measly Rs 820Cr
Talk to poor people , they are ready to die of covid rather than poverty.
It is better if covid appropriate behaviour is enforced which is unlikely for fear of loosing election. Even policemen are reluctant to repeat the enforcement seeing the the condition of poor people.
Actual ground report from rural doctors is very bad and people have thrown all caution to winds.
Better would have been to cut 20 percent yearly pay of 2 million employees to pay Rs 40000 Cr to poor people instead of measly Rs 820Cr
Talk to poor people , they are ready to die of covid rather than poverty.
It is better if covid appropriate behaviour is enforced which is unlikely for fear of loosing election. Even policemen are reluctant to repeat the enforcement seeing the the condition of poor people.
Actual ground report from rural doctors is very bad and people have thrown all caution to winds.
Re: Wuhan Coronavirus Resource Thread
Pfizer wanted Brazil, Argentina to put military bases, Federal reserve as collateral: Why India kept Pfizer away and how the usual suspects are wrong
Pfizer wanted Brazil, Argentina to put military bases, Federal reserve as collateral: Why India kept Pfizer away and how the usual suspects are wrong
Besides demanding safeguard from civil lawsuits, officials from Latin countries who were part of the negotiation revealed that the company also wanted protection against cases brought forth due to its own negligence, fraud or malice.
12 April, 2021
Jinit Jain
Indian left-liberals bat for Pfizer vaccine, even as the company is accused of high-level bullying by Latin countries
As India is afflicted by the resurgent wave of the coronavirus outbreak, with the indigenous-made vaccines running low on stocks, several individuals have used this adversity to urge the government to do away with the rules governing the approval of the emergency use of vaccines in India and allow Pfizer to sell its COVID-19 vaccines in India without conducting any bridge trials in the country.
With the daily coronavirus caseloads touching a new high, thanks to the inexorable spread of the infection in states like Maharashtra, the clamour for allowing Pfizer to sell its COVID-19 vaccine in the country has only grown stronger. Incidentally, the left-leaning and the self-proclaimed journalists are at the forefront of this campaign, pressurising the central government to waive off obligations that a vaccine manufacturing company has to fulfil before permitting them to sell their vaccines.
Earlier in February, the central government’s expert panel had rejected drugmaker Pfizer’s application seeking an emergency nod for its Covid-19 vaccine after the company insisted on a waiver of a clinical trial in India. The company wanted to sell its vaccine in India but was not inclined to hold the trials, which would have granted them the protection of being held responsible for any untoward side-effects caused among the recipients of its vaccine.
Latin countries accuse Pfizer of asking them to pledge sovereign assets, military bases to cushion against any adverse fallout of its vaccine
Apparently, India was not the only country where Pfizer wanted to ram its way through the vaccine market without being held accountable for any possible adverse outcomes. Latin countries had accused Pfizer of ‘high-level bullying’ during COVID-19 vaccine negotiations, alleging that the Pharma behemoth had demanded additional indemnity against civil lawsuits citizens might file in relation to Pfizer’s Covid-19 vaccine.
“Pfizer reportedly asked governments in Argentina and Brazil to put up sovereign assets, including military bases and federal bank reserves, as collateral for potential future legal costs,” a report published on Pharmaceutical Technology said.
Besides demanding safeguard from civil lawsuits, officials from Latin countries who were part of the negotiation revealed that the company also wanted protection against cases brought forth due to its own negligence, fraud or malice.
Indian left-liberals, foot soldiers of Pfizer’s PR campaign?
Despite the unreasonable demands made by Pfizer of the countries across the world, several motivated individuals want the Indian government to cave into the demands of the pharmaceutical giant and allow its vaccines to be sold in the country. This makes one wonder if the left-leaning liberals are unaware of Pfizer’s bullying tactics elsewhere in the world or are simply acting as foot-soldiers in the company’s PR campaign to railroad the Indian government into approving its vaccine.
A bridging trial is a supplementary trial performed in a new region or country to get more clinical data on efficacy, safety and dose regimen. But, the left-leaning liberals and journalists are now passionately arguing against holding clinical trials in the country and advocating its usage without trial. Ironically, these are the same set of folks who had demanded the Indian government to revoke the emergency use approval granted to indigenously made vaccines in January 2021. They had then argued that the clinical trials were not conducted and therefore vaccines should not be approved.
However, now they have changed their tune, asking for approval to the Pfizer vaccine even when the company has been accused by other countries of making unreasonable demands to protect itself from any repercussions resulting from the administration of its vaccines.
The left journalists have, more often than not, championed a cause that is detrimental to the country. Earlier in January 2021, when India needed rapid vaccination to avoid the resurgent wave of coronavirus outbreak, the left-leaning liberals had indulged in raising aspersions on the efficacy of the Made in India vaccines, thereby engendering doubts in the minds of people regarding the vaccines. The scepticism caused by their utterances delivered a significant blow to India’s vaccination drive and the country could have scaled its immunisation campaign much more quickly if the liberals had not raised questions on the vaccines made in India.
Now, a few months later, the left-leaning liberals have no qualms with a foreign company wanting to sell its vaccine without conducting trials here. In fact, they are passionately exhorting the government to forgo clinical trials for the foreign pharmaceutical company that is reported to have asked countries to pledge their sovereign assets, military bases and financial reserves to protect itself from any adverse fallout. This duplicity betrays where the loyalty of the Indian left-liberal journalists lies, and it is clearly not with India.
Re: Wuhan Coronavirus Resource Thread
^^^
Anytime someone strongly bashes left or right and makes it’s their core argument it’s not worth a mention. Too opinionated for any rational discourse.
Anytime someone strongly bashes left or right and makes it’s their core argument it’s not worth a mention. Too opinionated for any rational discourse.
Re: Wuhan Coronavirus Resource Thread
Interesting information in this article:
https://swarajyamag.com/news-brief/indi ... ually-rdif
https://swarajyamag.com/news-brief/indi ... ually-rdif
He said some companies are already producing Sputnik V, but the real ramp up of production will take two to three months over the summer.
Re: Wuhan Coronavirus Resource Thread
^^^ That's really good. Once we get to the summer inflection point, things get much better on supply side with all current options and new ones ramping up then.
Re: Wuhan Coronavirus Resource Thread
Remdesivir still making rounds for hospitalized patients.
UP govt ramps up measures to fight the resurgent COVID-19 outbreak, airlifts 25,000 doses of Remdesivir using govt plane from Gujarat
UP govt ramps up measures to fight the resurgent COVID-19 outbreak, airlifts 25,000 doses of Remdesivir using govt plane from Gujarat
India axes exports of Gilead Sciences' remdesivir, plots boost to local production as COVID cases mount: reportsAs the number of coronavirus cases in the state rise at an alarming pace, the Uttar Pradesh government has stepped up its efforts to blunt the new wave of COVID-19.
According to the sources, Uttar Pradesh is working on a war footing to tackle this sudden spike in the number of coronavirus cases. The government has released hundreds of crores of funds for procuring essential drugs, testing kits, N95 masks and PPE kits in its fight against the coronavirus.
The CM himself is reviewing the availability of medicines in the districts, and ensuring that there is adequate supply. The govt also arranged a large shipment of Remdesivir from Surat. The big consignment of Remdesivir vials arrived in Uttar Pradesh on Wednesday. Chief Minister Yogi Adityanath had ordered 25,000 doses of the injection keeping in view the spiralling cases of COVID-19 infection in the state recently....
India is one of the world's biggest manufacturers of drugs and vaccines, but that hasn't made it immune to COVID-19 supply instability. Now, the government is locking up at least one treatment for itself.
As COVID-19 cases mount—and demand for treatments spikes—India has banned exports of Gilead Sciences’ pandemic antiviral remdesivir, Bloomberg reports, citing a statement put out by the country’s health ministry Sunday. The news comes as local pharmas seek an emergency nod from the country's drug regulator to manufacture remdesivir off-license, according to Times of India.
Seven Indian companies are partnered with Gilead on remdesivir: Cipla, Hetero, Jubilant Life Sciences, Zydus Cadila, Dr Reddy’s, Mylan and Biocon’s Syngene. ...